Goldstone Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$564K Sell
4,391
-65
-1% -$7.61K 0.05% 172
2026
Q1
$536K Buy
4,456
+13
+0.3% +$1.5K 0.06% 162
2025
Q4
$468K Buy
4,443
+270
+6% +$25.3K 0.05% 168
2025
Q3
$350K Sell
4,173
-24
-0.6% -$1.98K 0.04% 179
2025
Q2
$340K Sell
4,197
-15
-0.4% -$1.19K 0.04% 175
2025
Q1
$378K Buy
4,212
+83
+2% +$7.75K 0.06% 153
2024
Q4
$411K Buy
4,129
+217
+6% +$22.4K 0.06% 141
2024
Q3
$444K Sell
3,912
-90
-2% -$10.7K 0.08% 129
2024
Q2
$496K Buy
4,002
+95
+2% +$12.2K 0.1% 112
2024
Q1
$516K Buy
3,907
+316
+9% +$39K 0.12% 102
2023
Q4
$391K Sell
3,591
-21
-0.6% -$2.18K 0.1% 105
2023
Q3
$372K Buy
3,612
+33
+0.9% +$3.56K 0.11% 105
2023
Q2
$413K Sell
3,579
-125
-3% -$14.2K 0.12% 102
2023
Q1
$394K Buy
+3,704
New +$400K 0.13% 95

Other funds holding MRK

Goldstone Financial Group's MRK Position: Q2 2026 in Review

Goldstone Financial Group reduced its Merck (MRK) stake by 1.5% in Q2 2026, selling an estimated $7.61K and leaving 4,391 shares worth $564K. The position accounts for 0.05% of the portfolio, ranked #172.

Goldstone Financial Group first reported a position in MRK in Q1 2023 and has held it in 14 quarters since. 3,847 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Goldstone Financial Group held 4,391 shares of Merck worth $564K as of Q2 2026.
  • Goldstone Financial Group sold 65 Merck shares in Q2 2026, an estimated $7.61K.
  • Merck made up 0.05% of Goldstone Financial Group's portfolio in Q2 2026, its #172 holding.
  • Goldstone Financial Group first reported a position in Merck in Q1 2023 and has held it in 14 quarters since.
  • 3,847 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Goldstone Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.